Collaborative VLP tech bolsters COVID-19 vaccine development
VLP platform using structural elements of coronavirus and modified surface spike molecules could be an ‘ideal’ for COVID-19 vaccine development.
Archives for August 26, 2020
SAM vaccine technology rapidly effective against Zika
Preclinical proof of concept study concludes SAM vaccine candidate delivered through CNE can rapidly elicit protective immunity against ZIKV, with potential use for additional antigens.
‘Snapping genetic Legos together’: Ufovax creates plug-and-play nanoparticle vaccine technology
Ufovax creates 1c-SApNP plug-and-play nanoparticle vaccine platform to target HIV, RSV, Ebola, and SARS-CoV-2.